These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1763794)

  • 41. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial.
    Ashraf H; Mahalanabis D; Mitra AK; Tzipori S; Fuchs GJ
    Acta Paediatr; 2001 Dec; 90(12):1373-8. PubMed ID: 11853331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Convalescent cultures for control of shigellosis outbreaks.
    Turabelidze G; Bowen A; Lin M; Tucker A; Butler C; Fick F
    Pediatr Infect Dis J; 2010 Aug; 29(8):728-30. PubMed ID: 20661101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergence of antibiotic resistant Shigella species: A matter of concern.
    Puzari M; Sharma M; Chetia P
    J Infect Public Health; 2018; 11(4):451-454. PubMed ID: 29066021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study.
    Reeves DS; Lacey RW; Mummery RV; Mahendra M; Bint AJ; Newsom SW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():99-105. PubMed ID: 6234282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical characteristics and antibiotic resistance of Shigella gastroenteritis in Ankara, Turkey between 2003 and 2009, and comparison with previous reports.
    Özmert EN; İnce OT; Örün E; Yalçın S; Yurdakök K; Gür D
    Int J Infect Dis; 2011 Dec; 15(12):e849-53. PubMed ID: 21982814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Existing status of shigellosis in Andaman & Nicobar islands.
    Ghosh AR; Sehgal SC
    Indian J Med Res; 1996 Mar; 103():134-7. PubMed ID: 9062037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.
    Miron D; Torem M; Merom R; Colodner R
    Pediatr Infect Dis J; 2004 Apr; 23(4):367-8. PubMed ID: 15071299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
    Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
    Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.
    Dagan D; Orr N; Yavzori M; Yuhas Y; Meron D; Ashkenazi S; Cohen D
    Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):887-9. PubMed ID: 12525926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nalidixic acid--a forgotten alternative].
    Miörner H; Rydberg J
    Lakartidningen; 1994 Dec; 91(49):4619. PubMed ID: 7808171
    [No Abstract]   [Full Text] [Related]  

  • 53. Single-dose tetracycline therapy for shigellosis in adults.
    Pickering LK; DuPont HL; Olarte J
    JAMA; 1978 Feb; 239(9):853-4. PubMed ID: 342737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shigella dysenteriae serotype 1, Kolkata, India.
    Dutta S; Dutta S; Dutta P; Matsushita S; Bhattacharya SK; Yoshida S
    Emerg Infect Dis; 2003 Nov; 9(11):1471-4. PubMed ID: 14718096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
    Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
    J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapy of bacillary dysentery].
    Gioieni A
    Clin Ter; 1980 Jan; 92(2):197-80. PubMed ID: 7389276
    [No Abstract]   [Full Text] [Related]  

  • 57. Changing antibiotic sensitivity patterns in shigellosis.
    Lamabadusuriya SP; Devasiri IV; Jayantha UK; Perera C
    Ceylon Med J; 1991 Dec; 36(4):159-61. PubMed ID: 1807844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India--a 5 year hospital based study.
    Mamatha B; Rituparna C
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1447-51. PubMed ID: 23413708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of health services utilization on the recovery from dysentery.
    Myaux JA; Chakraborty J; Yunus M; Khan EH; de Francisco A
    J Trop Pediatr; 1996 Feb; 42(1):38-42. PubMed ID: 8820619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Shigellosis in children: a prospective hospital based study.
    Dutta P; Bhattacharya SK; Sen D; Bhattacharya MK; Mitra U; Rasaily R; Manna B; Mukherjee A; Pal SC
    Indian Pediatr; 1992 Sep; 29(9):1125-30. PubMed ID: 1452309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.